Glancy prongay & murray llp, a leading securities fraud law firm, announces investigation of amryt pharma plc (amyt) on behalf of investors

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of amryt pharma plc (“amryt ” or the “company”) (nasdaq: amyt) investors concerning the company's possible violations of the federal securities laws. if you suffered a loss on your amryt investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, y
AMYT Ratings Summary
AMYT Quant Ranking